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SuMMAry – breast cancer is the most common malignancy in the population of women under 
40 years of age. young age is an independent factor for poor prognosis. In this research, we tried to 
establish other factors for poor prognosis in stage I-III breast cancer. The following parameters were 
observed: tumor size, lymph node status, histologic grade, hormonal receptor status, Ki-67 prognostic 
index, her2 neu status, histologic type of the tumor, local recurrence and metastases. Logistic regres-
sion was used to evaluate the effect of specific factors on the probability of lethal outcome and devel-
opment of distant metastases. Our patients showed a predominance of t1 tumor (49.4%), had positive 
lymph nodes (62%) and most of them were pn1 (61.2%). up to one-third of patients had triple 
negative status. Ki-67 proliferation index was high (25%). Multicentric tumor was detected in 23% of 
patients. There was no difference in overall survival between the two types of surgical procedures. Pa-
tients with pn0 status had better overall survival. breast cancer in the population of young women has 
a more aggressive nature. Study results indicated positive lymph node status as an independent factor 
for poor prognosis of stage I-III breast cancer.
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Introduction
breast cancer represents a global public health issue. 
It is the most common malignancy and mortality factor 
in the population of women. due to the expansion of 
novel therapeutic options, from surgical and oncologic 
perspective, and with greater potential for recovery, 
breast cancer is one of the most researched malignancies 
in the past twenty years. young women with breast can-
cer are considered to be those under 40 years of age1,2. In 
this population, breast carcinoma represents the most 
common malignant disease with highest mortality, al-
though breast cancer accounts for 6% of the total num-
ber of cancer cases3. numerous clinical studies have 
confirmed that breast cancer in young women has a 
higher histologic grade, unfavorable hormonal status, 
and overall higher death rate compared to the older 
population of women4-6. young age is an adverse prog-
nostic factor in primary breast cancer. Various studies 
found young women to have worse outcomes than older 
patients7,8. young age is also an independent risk factor 
for disease-free survival (dfS) and overall survival (OS) 
in women with operable breast cancer9,10. In the group 
of young women, there are limited data on prognostic 
factors. Only a few studies recognize nodal status, estro-
gen receptor status and molecular subtype as indepen-
dent factors for poor survival11,12.
we recognized young age as an independent factor 
for poor prognosis but also wanted to establish other 
possible independent factors for dfS and OS in the 
group of young women with breast cancer from our 
population.
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Patients and Methods
This was a retrospective study. data were collected 
from medical charts of young female patients having 
undergone surgical treatment at the department of 
Surgery, Osijek university hospital Centre, Osijek, 
Croatia, during the 2002-2010 period. Study patients 
were under 40 years of age at the time of surgery. data 
on the following parameters were collected: tumor 
size, lymph node status, histologic grade, hormonal re-
ceptor status, Ki-67 prognostic index, her2 neu status, 
histologic type of tumor, local recurrence, metastases, 
and outcome (alive or death). All patients included in 
the study had complete medical documentation. Those 
with incomplete documentation and data were exclud-
ed from the study. All study patients had stage I-III 
tumor. Patients who had positive distant metastasis 
(M) at the time of diagnosis were not included in the 
study. All patients were monitored during routine and 
urgent checkups. All patients included in this study 
were monitored for 5-13 (median 8.7) years. we col-
lected data on 79 young female patients, median age 
37 (range 33-39) years.
breast tissue was fixed, embedded in paraffin and 
cut into 5-µm sections. After that, it was stained and 
observed under a microscope. hormonal status, her2 
neu status and Ki 67 were determined by immuno-
chemical staining. Among patients with her2 neu 2+, 
the fISh method was performed to determine wheth-
er the patient was her2 neu positive or negative. his-
tologic grading of breast carcinoma was performed by 
elston and ellis method. we used the tnM (tumor-
nodes-metastases) classification of the American Joint 
Committee on Cancer Staging System for breast 
Cancer, 201013,14.
Local recurrence is defined as recurrence in the 
field of mastectomy or in the original tumor location 
for breast conserving resection. Local recurrence was 
diagnosed pathologically after surgical biopsy. Metas-
tases are defined as recurrence of the tumor in distant 
organ during regular or urgent follow up examinations 
using abdominal ultrasound, lung radiography, bone 
scintigraphy, surgical biopsy, computed tomography 
(Ct), magnetic resonance imaging (MrI) and posi-
tron emission/computed tomography (Pet/Ct) 
scans. Outcome was defined as the patient being dead 
or alive at the end of the follow up period.
Table 1. Study parameters in young women with breast 
cancer
Affected side, n (%)
right 40 (50.6)
left 39 (49.4)
Histologic type, n (%)
ductal invasive 56 (70.9)
lobular invasive 11 (13.9)
other 12 (15.2)
Tumor size (T), n (%)
t1 ≤2 cm 39 (49.4)
t2 >2 cm, ≤5cm 30 (38)
t3 >5 cm 7 (8.9)
t4 any size with skin or chest wall 
spread 3 (3.8)
Positive lymph nodes, n (%) 49 (62)
Lymph nodes status, n (%)
1-3 lymph nodes 30 (61.2)
4-9 lymph nodes 13 (26.5)
≥10 lymph nodes 6 (12.2)
Estrogen status, n (%)
negative 36 (45.6)
positive 43 (54.4)
Progesterone status, n (%)
negative 35 (44.3)
positive 44 (55.7)
HER2 neu status, n (%)
negative 60 (75.9)
positive 19 (24.1)
triple negative, n (%) 25 (32.1)
Ki67, median (25%-75%) 25 (11-48)
Type of surgical procedure, n (%)
modified radical mastectomy 52 (65.8)
breast conserving resection 27 (34.2)
Multicentric tumor position, n (%) 18 (23.1)




Local recurrence, n (%) MrM 0 (0)
bCr 3 (3.8)
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Statistical analysis was performed with SPSS 13.0 
(Chicago, IL, uSA) software. Logistic regression (uni-
variate and multivariate) was used to evaluate the im-
pact of several factors on the probability of negative 
outcome in study subjects.
Table 2. Impact of parameters on prediction of lethal outcome (univariate regression analysis)
Variable β p Odds ratio(Or)
95% confidence 
interval



































positive -1.073 0.04 0.342 0.105-0.812
Progesterone
negative
positive -0.785 0.18 0.456 0.145-1.44
HER2 neu
negative
positive -0.288 0.68 0.750 0.188-2.9
Ki-67 (%) 0.019 0.03 1.019 0.797-0.97
Type of surgery
bCr
MrM 0.875 0.21 2.4 0.614-9.4
Multicentric position
no
yes 1.041 0.09 2.833 0.845-9.49
Triple negative
no
















yes 2.271 0.07 9.692 0.82-114.9
Metastases
no
yes 22.119 0.997 4.0x109 0
bCr = breast conserving resection; MrM = modified radical mastectomy
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Results
data were collected on 79 patients, median age 37 
(range 33-39) years (table 1). There were no signifi-
cant differences according to the side operated on. In-
vasive ductal carcinoma was the most common histo-
logic type of tumor (70.9%). Invasive lobular carcino-
ma was the second most common type (13.9%).
regarding the size of the tumor, most patients had 
t1 and t2 (87.4%) tumor size, with a predominance 
of tumor size ≤2cm (49.4%). The majority of patients 
had positive lymph nodes (62%), most of them with 
pn1 status (1-3 positive nodes; 61.2%). There were no 
significant differences in estrogen or progesterone sta-
tus. The majority of patients were her2 neu negative 
(75.9%) and up to one-third of patients had triple 
negative immunohistochemical status. Ki-67 prolifer-
ation index was rather high (25%; interquartile range 
11% to up to 46%). we found a high incidence of mul-
ticentric tumors (n=18, 23.15%) in our group of young 
women. More than one-half of patients were histology 
grade II (54.4%) (table 1).
Modified radical mastectomy was the preferred type 
of surgical procedure, performed in 65.8% of patients. 
Only three patients developed local recurrence. They all 
were primarily treated with breast conserving resection.
At the end of follow up, metastases were detected in 
26.6% of patients and 15 (19%) of them died (table 1).
Effect of parameters on predicting lethal outcome
Logistic regression was used to estimate the poten-
tial impact of specific factors on the possible lethal out-
come in the study group of patients. The model con-
tains fourteen parameters: age, histologic type, tumor 
size, lymph node status, estrogen status, progesterone 
status, her2 neu, Ki-67, type of surgical procedure, 
multicentric position, triple negative status, histology 
grade, local recurrence, and metastases (table 2).
from the predictor variables that showed statistical 
significance, and exclusion of variables that did not 
change the probability (P) model by 20%, the follow-
ing five variables were selected for the model on which 
to apply multivariate logistic regression: estrogen and 
progesterone positive status, lymph node status, Ki-67, 
and local recurrence. The model was statistically sig-
nificant, χ2=20.4 (df=7, p=0.005), and explained be-
tween 22.7% (after Cox & Snell) and 36.6% (after 
negelkerke) of variance for death outcome, and accu-
rately classified 86.1% of cases. The strongest indepen-
dent factor for death outcome was lymph node status 
(table 3).
Effect of parameters on predicting development  
of metastases
The probability of developing distant metastases in 
the study sample was evaluated by screening for the spe-
cific factors applying the logistic regression methods. 
The model contains thirteen parameters: age, histologic 
type, tumor size, lymph node status, estrogen status, 
progesterone status, her2 neu, Ki-67, type of surgical 
procedure, multicentric position, triple negative status, 
histology grade, and local recurrence (table 4).
four predictor variables that showed statistical sig-
nificance were chosen for the model on which multi-
Table 3. Impact of parameters on prediction of lethal outcome (multivariate regression analysis)



















estrogen positive -1.856 0.14 0.156 0.013-1.871
Progesterone positive 0.677 0.57 1.968 0.191-20.296
Ki-67 (%) 0.019 0.17 1.019 0.992-1.048
Local recurrence
yes 2.240 0.12 9.398 0.553-159.78
Constant -3.843 0.005 0.021
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variate logistic regression was applied. These variables 
were found to be predictors for metastasis develop-
ment: age, lymph node status, estrogen status and mul-
ticentric position. The model was statistically signifi-
cant, χ2=20.1 (df=5, p=0.001), and explained between 
22.5% (after Cox & Snell) and 32.7% (after negelker-
ke) of variance for metastasis development, and accu-
rately classified 78.5% of cases. The strongest inde-
pendent factor for metastases was lymph node status 
(table 5).
Table 4. Impact of parameters on prediction of metastasis development (univariate regression analysis)
Variable β p Odds ratio(Or)
95% confidence 
interval



































positive -0.905 0.08 0.404 0.145-1.128
Progesterone
negative
positive -0.708 0.17 0.493 0.179-1.356
HER2 neu
negative
positive 0.651 0.25 1.917 0.633-5.802
Ki-67 (%) 0.007 0.52 1.007 0.987-1.027
Type of surgery
bCr
MrM -0.671 0.25 0.511 0.164-1.592
Multicentric position
no
yes 1.386 0.015 4 1.305-12.256
Triple negative
no
















yes 22.37 0.99 5.2 x109 0
bCr = breast conserving resection; MrM = modified radical mastectomy
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Kaplan-Meier’s analysis of survival
Kaplan-Meier’s analysis of survival was applied in 
patients with distant metastases. Patients without pos-
itive lymph node (n=8) had OS at 7.8 years (95% CI 
7.3-8,2). Patients with n1 (n=27) had OS at 6.5 years 
(95% CI 5,6-7,4). Lowest OS was recorded in patients 
with n2 (n=13), at 5.2 years (95% CI 3.8-6.7). Pa-
tients with n3 (n=3) had OS at 6.7 years (95% CI 
3.8-9.5). Patients with positive n had poor OS, but 
without differences according to the number of posi-
tive nodes (Mantel-Cox test, p=0.08) (fig. 1).
The mean survival period in our group of young pa-
tients was 7.3 years (95% CI 6.6 to 8.1). Survival time 
of patients operated on with modified radical mastec-
tomy with axillary dissection was 6.8 years (95% CI 5.7 
to 7.8), and of patients operated on with breast con-
serving resection 7.3 years (95% CI 6.6-8), with no sig-
nificant difference (Mantel-Cox test, p=0.13) (fig. 2).
Table 5. Impact of parameters on prediction of metastasis development (multivariate regression analysis)





















estrogen positive -1.52 0.03 0.219 0.054-0.885
Age -0.160 0.05 0.852 0.723-1.003
Multicentric position, yes 0.719 0.39 2.052 0.054-0.885
Constant 3.854 0.18 47.1
Fig. 1. Kaplan-Meier’s analysis of survival with lymph node involvement.
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Discussion
breast cancer in the population of young women 
accounted for only 5%-7% of all breast cancer pa-
tients3. In far east countries, the incidence of breast 
cancer in young patients was found to be twofold that 
in developed countries10. breast cancer among young 
women is considered to have a more aggressive nature 
and higher tumor grade with more vascular invasion 
than breast cancer in older women4. when compared 
to older women, breast cancer in younger women tends 
to have a worse prognosis in terms of OS and dfS9,10. 
young age has been identified as an independent fac-
tor for poor prognosis9,15.
In our sample, we found invasive ductal carcinoma 
as the most frequent histologic type of tumor. The sec-
ond most common type was invasive lobular carcino-
ma. Among other different studies, rosenberg et al. in 
their case-control study confirmed invasive ductal car-
cinoma as the most frequent one, and invasive lobular 
carcinoma as the second most common16,17. we found 
a predominance of tumors smaller than 5 cm, espe-
cially t1, which is consistent with the findings report-
ed by Colleoni et al.18. Prognostic value of tumor size is 
independent of the state of lymph nodes. Patients with 
small tumors have better prognosis19,20. The prognosis 
of multicentric tumor is worse than for solid tumors of 
similar size (often axillary metastases)21. Multicentric 
cancer has worse biologic behavior with frequently 
present multiple foci and therefore should be consid-
ered in planning adjuvant treatments22. we found a 
rather high proportion of multicentric breast cancer.
Positive axillary lymph nodes have been considered 
as the most important prognostic factor for poor prog-
nosis of breast cancer patients19. we found the major-
ity of our patients to have positive lymph nodes. Our 
positive lymph node patients had worse OS and dfS 
(positive distant metastases) than lymph node negative 
patients, however, without difference between pn1-
pn3 lymph node status. This is somewhat different 
from the findings reported from one study, which es-
tablished difference in OS between pn1 and a greater 
number of lymph nodes involved23. tai et al. also report 
on difference in prognosis within pn1 group between 
1-2 and 3 lymph nodes involved24. Our findings might 
be somewhat imprecise due to the small sample size.
Fig. 2. Kaplan-Meier’s analysis of survival with type of surgical procedure.
bCr = breast conserving resection; MrM = modified radical mastectomy
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triple-negative breast cancer is more aggressive, 
more likely to metastasize, and has more frequent re-
currences after treatment. This is visible in the first 5 
years after treatment. generally, triple negative breast 
cancer has poor prognosis and higher mortality rate 
compared to other molecular subtypes25. In our study 
sample, up to one-third of patients were triple nega-
tive. Studies emphasize that the Ki-67 index ≥20 is a 
poor prognostic sign. breast cancer patients with high 
Ki-67 had a significantly worse prognosis due to local 
recurrence, distant metastasis and poor OS26,27. In our 
study, Ki-67 was found to be 25%, which is a high 
value pointing to poor prognosis of the disease in our 
group of young women.
when compared with modified radical mastecto-
my, breast conserving surgery is similar in OS and the 
chance for distant metastasis development. Of course, 
breast conserving resection must be combined with ra-
diotherapy. breast conserving resection has more local 
recurrences; all local recurrences in our sample were in 
the breast conserving resection group. we proved that 
there was no difference between these two surgical 
procedures in OS, which is consistent with recent lit-
erature28,29.
On statistical analysis, we identified local recur-
rence, hormone receptor status, lymph node status and 
Ki-67 index as predictors of poor OS. Lymph node 
status, hormone receptor status and multicentric posi-
tion were predictive of developing distant metastases. 
however, lymph node status was an independent fac-
tor for both OS and dfS. Other authors recognize 
hormone receptor status and lymph node status as pre-
dictors of poor prognosis11,12.
Conclusion
breast cancer in the population of young women 
has a more aggressive nature, positive lymph nodes, of-
ten triple negative molecular subtype, high Ki-67 in-
dex, multicentric tumor position and distant metasta-
ses. These are predictors of poor prognosis, but positive 
lymph node status is an independent prognostic factor 
for OS and dfS.
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Sažetak
neOVISnI ČIMbenICI ZA LOŠu PrOgnOZu  
KOd MLAdIh bOLeSnICA S rAKOM dOJKe I.-III. StAdIJA
I. Erić, A. Petek Erić, I. Koprivčić, M. Babić, S. Pačarić i B. Trogrlić
rak dojke je najčešći zloćudni tumor u populaciji žena u dobi ispod 40 godina. Mlada dob je neovisan čimbenik za lošu 
prognozu. Željeli smo utvrditi i druge čimbenike loše prognoze kod raka dojke I.-III. stadija kod mlade populacije žena. 
uzeli smo u obzir sljedeće parametre: veličinu tumora, stanje limfnih čvorova, histološki stupanj, status hormonskih recep-
tora, Ki-67 prognostički indeks, her2 neu status, histološki tip tumora, lokalni recidiv i razvoj udaljenih metastaza. Logi-
stička regresija korištena je za procjenu utjecaja čimbenika na vjerojatnost smrtnog ishoda i razvoja udaljenih metastaza. naše 
bolesnice imale su većinom tumor t1 (49,4%), pozitivne limfne čvorove (62%), a većina njih bile su pn1 (61,2%). do jedne 
trećine bolesnica imale su trostruko negativan hormonski status. Ki-67 indeks proliferacije bio je visokih 25%. našli smo 
učestalost multicentričnog tumora kod 23% bolesnice. nije bilo razlike u preživljenju između dviju vrsta kirurškog zahvata. 
bolesnice sa statusom limfnih čvorova pn0 imale su bolje preživljenje. rak dojke kod mlade populacije žena ima agresivniju 
prirodu. rezultati istraživanja ukazali su na pozitivan status limfnih čvorova kao nezavisan čimbenik za lošu prognozu raka 
dojke I.-III. stadija.
Ključne riječi: Karcinom dojke; Mlade žene; Multivarijatna analiza; Nezavisni čimbenik rizika
